Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Zero Based Budgeting equips learners with practical financial literacy: budgeting steps, tracking methods, and how to align money with priorities.
28,655 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
When a new Fed chair takes the podium, investors watch not just for rate hints but for what isn’t said. This piece br...
A crypto analyst challenges Ripple’s CEO over Strategy’s BTC funding model as BTC and XRP markets react to evolving f...
A new nonprofit, Ethereum Institutional, launches to act as a neutral entry point for institutions exploring Ethereum...
Volatility creates noise, but it can also reveal the best buying opportunity months for patient investors. Learn wher...
A high-profile fund manager dumped a huge chunk of AMD stock in one day. The move sparked questions about portfolio s...
Off the field, Haaland maps a broader financial playbook, backing chess events, an investment firm, and a film role a...
A 56-year-old investor with $3.2M saved confronts a healthcare-cost hurdle that could push retirement beyond mid-50s....
Ripple unveils strategic deals and a ledger upgrade to boost adoption. XRP trades around $0.65, with meaningful insti...
When a company’s chairman unloads a sizable stake, investors naturally want to know why. This article breaks down a r...